ARCHIVES

2006 demonstration project to pay $23 per office visit.

This article is from The Cancer Letter archive.

Vol. 31 No. 40 | November 4, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Study Sections Use New Scoring Procedure

July 3, 1998

NCI Audit Finds “Low Quality” Research At Calif. Foundation

June 17, 1994

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

Fisher Committee Suggest Program, NCI Changes To Enhance Surgical Oncology

April 1, 1977

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990